• LAST PRICE
    5.4700
  • TODAY'S CHANGE (%)
    Trending Up0.0100 (0.1832%)
  • Bid / Lots
    5.4200/ 1
  • Ask / Lots
    5.5500/ 6
  • Open / Previous Close
    5.4400 / 5.4600
  • Day Range
    Low 5.3100
    High 5.4900
  • 52 Week Range
    Low 4.0000
    High 7.3400
  • Volume
    114,519
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Tuesday's close: 5.46
TimeVolumeKMPH
09:32 ET1505.44
09:39 ET15715.4
09:44 ET3005.3832
09:46 ET11005.38
10:02 ET3005.42
10:04 ET5005.41
10:06 ET11625.45
10:08 ET8005.4583
10:09 ET7965.4301
10:11 ET3005.46
10:15 ET2005.465
10:18 ET1005.465
10:22 ET1005.465
10:24 ET1005.45
10:26 ET1005.46
10:40 ET1005.4475
10:42 ET3005.4439
10:44 ET5005.44
10:45 ET15195.41
10:47 ET74255.395
10:51 ET3005.39
10:56 ET1005.38
10:58 ET14005.38
11:02 ET3005.37
11:03 ET27205.39
11:05 ET1005.38
11:07 ET2005.38
11:12 ET1005.38
11:14 ET2575.3875
11:16 ET23765.39
11:27 ET1005.41
11:30 ET6005.42
11:34 ET2005.42
11:41 ET1195.43
11:45 ET4005.42
11:48 ET2005.4293
11:50 ET1005.4201
11:52 ET3005.43
11:54 ET3005.43
11:57 ET3435.42
11:59 ET2485.42
12:03 ET3995.41
12:08 ET1005.41
12:10 ET2005.41
12:19 ET2005.4021
12:21 ET1005.405
12:24 ET8005.4
12:26 ET2005.39
12:28 ET5005.37
12:30 ET3005.37
12:32 ET3005.37
12:33 ET5505.37
12:35 ET1005.37
12:37 ET2005.37
12:39 ET13695.38
12:42 ET2005.38
12:44 ET3005.37
12:46 ET14955.35
12:48 ET10165.35
12:50 ET4005.33
12:51 ET1005.36
12:53 ET3005.35
12:55 ET2735.35
12:57 ET3005.34
01:00 ET2005.34
01:02 ET2005.345
01:04 ET2005.34
01:06 ET3005.34
01:08 ET6005.35
01:11 ET3005.34
01:13 ET1005.349
01:18 ET6255.34
01:20 ET2005.33
01:22 ET3505.34
01:24 ET1005.34
01:26 ET2005.34
01:27 ET2005.34
01:29 ET21195.34
01:36 ET2005.34
01:54 ET1005.35
02:00 ET1005.36
02:02 ET5435.34
02:03 ET1005.355
02:07 ET21005.37
02:09 ET1005.3964
02:12 ET13245.41
02:16 ET2005.42
02:18 ET2005.41
02:30 ET5005.42
02:32 ET16855.42
02:34 ET1005.41
02:36 ET109835.37
02:41 ET20005.408
02:43 ET3505.42
02:45 ET1005.4292
02:48 ET4005.44
02:50 ET2305.44
02:52 ET16005.445
02:54 ET7005.44
02:56 ET5005.43
02:59 ET6005.435
03:01 ET4005.44
03:03 ET8465.45
03:06 ET11105.46
03:08 ET8105.4897
03:10 ET3005.4863
03:12 ET1005.48
03:14 ET2005.47
03:15 ET6925.46
03:19 ET1005.45
03:21 ET2365.46
03:26 ET2005.451
03:30 ET1005.45
03:32 ET4005.45
03:33 ET2005.45
03:35 ET3005.47
03:37 ET3005.48
03:42 ET1005.48
03:46 ET1005.49
03:48 ET7005.48
03:50 ET5005.47
03:51 ET9005.45
03:53 ET10005.45
03:55 ET8005.455
03:57 ET11475.45
04:00 ET13345.47
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesKMPH
KemPharm Inc
188.4M
-5.4x
---
United StatesSTTK
Shattuck Labs Inc
176.8M
-2.5x
---
United StatesYMAB
Y-mAbs Therapeutics Inc
196.1M
-1.5x
---
United StatesIKNA
Ikena Oncology Inc
154.5M
-2.9x
---
United StatesSLGL
Sol Gel Technologies Ltd
131.5M
30.9x
---
United StatesSESN
Sesen Bio Inc
125.4M
-34.9x
---
As of 2023-02-01

Company Information

KemPharm, Inc. (KemPharm) is a specialty pharmaceutical company focused on the discovery and development of treatments for central nervous system (CNS), and rare disease indications, including attention deficit hyperactivity disorder (ADHD), stimulant use disorder (SUD) and idiopathic hypersomnia (IH). It is focused on the discovery and development of prodrugs to treat serious medical conditions through its Ligand Activated Therapy (LAT) technology. KemPharm utilizes its LAT technology to generate prodrug versions of Food and Drug Administration (FDA) approved drugs. KemPharm's lead clinical development product candidate for the treatment of IH and narcolepsy, KP1077, is based on serdexmethylphenidate (SDX), its prodrug of d-methlyphenidate (d-MPH). Its prodrug product candidate for the treatment of SUD is KP879. In addition, KemPharm has received FDA approval for AZSTARYS, a once-daily treatment for ADHD in patents age six years and older.

Contact Information

Headquarters
1180 Celebration Blvd Ste 103CELEBRATION, FL, United States 34747-4950
Phone
321-939-3416
Fax
319-665-2577

Executives

Independent Chairman of the Board
Matthew Plooster
Chief Executive Officer, Director
Richard Pascoe
Chief Financial Officer, Treasurer, Secretary
R. LaDuane Clifton
Executive Vice President - Research and Development
Sven Guenther
Vice President, Corporate Controller
Timothy Sangiovanni

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$188.4M
Revenue (TTM)
$10.7M
Shares Outstanding
34.5M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
2.16
EPS
$-1.02
Book Value
$3.63
P/E Ratio
-5.4x
Price/Sales (TTM)
17.6
Price/Cash Flow (TTM)
---
Operating Margin
-336.67%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.